Skip to main content
Signal8
Launch Terminal

Decoy Therapeutics Inc. (DCOY)

Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Decoy Therapeutics Inc. logo

Decoy Therapeutics Inc.

NASDAQ:DCOYHealthcare
-13.01%$1.07
AH$1.08+0.93%vs close
Mkt Cap$2.55M
Float2.25M
O/S2.39M
Vol
$ Vol
RVOL
Inst Own0.2%
SI4.3%
Earnings
Dilution
Decoy Therapeutics Inc. logoNASDAQ:DCOY$1.07-13.01%
FormDescription
EFFECT
Notice of Effectiveness
1
424B3
Prospectus
7
S-1
Registration Statement
6
8-K
1.01,3.02,7.01,9.01
4
8-K
5.07
3
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
13G
Beneficial Ownership Report
10-Q
Quarterly Report
8
DEF 14A
Definitive Proxy Statement
7
DEFA14A
Additional Proxy Materials
3
Initial Statement of Beneficial Ownership
PRE 14A
Preliminary Proxy Statement
4
EFFECT
Notice of Effectiveness
424B3
Prospectus
5
8-K
5.07
S-1
Registration Statement
5

1-25 of 743

…

Recent SEC filings with analysis